tiprankstipranks
pc:akrib

Akribion Therapeutics

Akribion Therapeutics is an early-stage biotechnology company specializing in the development of a unique RNA-guided, nuclease-based technology for programmable cell depletion. The company's proprietary G-dase® E nucleases aim to advance novel therapeutic solutions, leveraging an experienced team with expertise in biotechnology and company building.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$8M
Total Amount Raised$8M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$8M
Latest Funding Amount$8M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Feb 04, 2025
Seed Round
$8.00M

Investors

Investor Name
Funding Round
Seed Round
Seed Round

Related News and Analysis